Disseminated intravascular coagulation epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 7: | Line 7: | ||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
===Incidence=== | ===Incidence=== | ||
*The incidence of DIC | *The incidence of [[DIC]] is different in different [[diseases]] as it is almost always related to a life threatening condition. | ||
*In 2010, the incidence of DIC was estimated to be 26.2 cases per 100,000 individuals worldwide.<ref name="pmid23139140">{{cite journal |vauthors=Singh B, Hanson AC, Alhurani R, Wang S, Herasevich V, Cartin-Ceba R, Kor DJ, Gangat N, Li G |title=Trends in the incidence and outcomes of disseminated intravascular coagulation in critically ill patients (2004-2010): a population-based study |journal=Chest |volume=143 |issue=5 |pages=1235–1242 |date=May 2013 |pmid=23139140 |doi=10.1378/chest.12-2112 |url=}}</ref> | *In 2010, the [[incidence]] of [[DIC]] was estimated to be 26.2 cases per 100,000 individuals worldwide.<ref name="pmid23139140">{{cite journal |vauthors=Singh B, Hanson AC, Alhurani R, Wang S, Herasevich V, Cartin-Ceba R, Kor DJ, Gangat N, Li G |title=Trends in the incidence and outcomes of disseminated intravascular coagulation in critically ill patients (2004-2010): a population-based study |journal=Chest |volume=143 |issue=5 |pages=1235–1242 |date=May 2013 |pmid=23139140 |doi=10.1378/chest.12-2112 |url=}}</ref> | ||
===Prevalence=== | ===Prevalence=== | ||
*The | *The prevalence of DIC depends on the clinical settings, higher versus low acquity settings. | ||
*In [year], the incidence/prevalence of [disease name] was estimated to be 18.6 per 100,000 individuals worldwide. | *In [year], the incidence/prevalence of [disease name] was estimated to be 18.6 per 100,000 individuals worldwide. | ||
*The prevalence of [disease/malignancy] is estimated to be [number] cases annually. | *The prevalence of [disease/malignancy] is estimated to be [number] cases annually. | ||
Revision as of 16:16, 23 August 2018
|
Disseminated intravascular coagulation Microchapters |
|
Differentiating Disseminated intravascular coagulation from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Disseminated intravascular coagulation epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Disseminated intravascular coagulation epidemiology and demographics |
|
FDA on Disseminated intravascular coagulation epidemiology and demographics |
|
CDC on Disseminated intravascular coagulation epidemiology and demographics |
|
Disseminated intravascular coagulation epidemiology and demographics in the news |
|
Blogs on Disseminated intravascular coagulation epidemiology and demographics |
|
Directions to Hospitals Treating Disseminated intravascular coagulation |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Omer Kamal, M.D.[2]
Overview
Epidemiology and Demographics
Incidence
- The incidence of DIC is different in different diseases as it is almost always related to a life threatening condition.
- In 2010, the incidence of DIC was estimated to be 26.2 cases per 100,000 individuals worldwide.[1]
Prevalence
- The prevalence of DIC depends on the clinical settings, higher versus low acquity settings.
- In [year], the incidence/prevalence of [disease name] was estimated to be 18.6 per 100,000 individuals worldwide.
- The prevalence of [disease/malignancy] is estimated to be [number] cases annually.
Case-fatality rate/Mortality rate
- In [year], the incidence of [disease name] is approximately [number range] per 100,000 individuals with a case-fatality rate/mortality rate of [number range]%.
- The case-fatality rate/mortality rate of [disease name] is approximately [number range].
Age
- Patients of all age groups may develop [disease name].
- The incidence of [disease name] increases with age; the median age at diagnosis is [#] years.
- [Disease name] commonly affects individuals younger than/older than [number of years] years of age.
- [Chronic disease name] is usually first diagnosed among [age group].
- [Acute disease name] commonly affects [age group].
Race
- There is no racial predilection to [disease name].
- [Disease name] usually affects individuals of the [race 1] race. [Race 2] individuals are less likely to develop [disease name].
Gender
- [Disease name] affects men and women equally.
- [Gender 1] are more commonly affected by [disease name] than [gender 2]. The [gender 1] to [gender 2] ratio is approximately [number > 1] to 1.
Region
- The majority of [disease name] cases are reported in [geographical region].
- [Disease name] is a common/rare disease that tends to affect [patient population 1] and [patient population 2].
Developing Countries
References
- ↑ Singh B, Hanson AC, Alhurani R, Wang S, Herasevich V, Cartin-Ceba R, Kor DJ, Gangat N, Li G (May 2013). "Trends in the incidence and outcomes of disseminated intravascular coagulation in critically ill patients (2004-2010): a population-based study". Chest. 143 (5): 1235–1242. doi:10.1378/chest.12-2112. PMID 23139140.